The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting

The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting The Washington Post Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest The Guardian Weight-loss jabs ‘slash cancer risk and boost survival rates’ The Times Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study New York Post Weight-loss drugs linked to lower breast cancer rates. What to know USA Today